– The American Medical Affiliation (AMA) has added new codes to the Present Procedural Terminology (CPT) code set to account for the COVID-19 vaccine candidate from Janssen Pharmaceutica, a division of Johnson & Johnson.
The codes – 91302 and 0031A – can be utilized to doc and invoice for Janssen’s single-dose vaccine and its administration when the Meals and Drug Administration (FDA) approves the vaccine candidate or grants it emergency use authorization, in line with a current announcement.
Janssen’s COVID-19 vaccine is the fourth vaccine candidate to get its personal CPT code from AMA, following the candidates from Pfizer, Moderna and AstraZeneca. The Affiliation beforehand issued distinctive CPT codes for the three vaccine candidates and immunization administration, together with the primary and second doses of the two-dose vaccines from all three corporations.
“Janssen’s single-dose COVID-19 vaccine would mark an enormous change from the double-dose vaccines presently out there,” mentioned Susan R. Bailey, MD, AMA president and CEO, mentioned within the announcement. “The change will place larger significance on precisely reporting COVID-19 immunizations by vaccine sort and dose to make sure sufferers full the suitable immunization schedule.”
“Distinctive CPT codes that clinically distinguish every COVID-19 vaccine present the wanted informational precision to make sure optimum vaccine distribution and administration,” Bailey said.
An FDA approval for the COVID-19 vaccine from Janssen continues to be “weeks away,” in line with the nation’s high infectious illness skilled Anthony Fauci who spoke with NBC’s “Meet the Press” on Sunday.
However the single-dose vaccine candidate is producing constructive outcomes, in line with Johnson & Johnson.
The pharmaceutical firm launched knowledge from an interim Part 1/2a scientific trial late final week exhibiting that the investigational COVID-19 vaccine candidate (JNJ-78436735) supplied an immune response for not less than 71 days.
JNJ-78436735 was additionally well-tolerated throughout all examine individuals, the info revealed.
Johnson & Johnson, which has funneled growth of the vaccine candidate to Janssen, expects extra knowledge from a Part three scientific trial in late January 2021, when it plans to submit an utility for emergency use authorization to the FDA if outcomes present the vaccine candidate to be protected and efficient.
However “time is approximate,” the corporate said, for the reason that trial is “dependent on disease events.”
AMA developed distinctive CPT codes for the AstraZeneca vaccine and its administration in December 2020.
The newest codes to be added to the CPT code set are:
- 91303: Extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus illness [COVID-19]) vaccine, DNA, spike protein, adenovirus sort 26 (Advert26) vector, preservative free, 5×1010 viral particles/0.5mL dosage, for intramuscular use
- 0031A: Immunization administration by intramuscular injection of extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus illness [COVID-19]) vaccine, DNA, spike protein, adenovirus sort 26 (Advert26) vector, preservative free, 5×1010 viral particles/0.5mL dosage, single dose
Different vaccine-specific CPT codes authorized by the AMA embody codes 91302, 0021A, and 0022A for AstraZeneca’s vaccine and administration; 91300, 0001A, and 0002A for Pfizer’s vaccine and administration; and 91301, 0011A, and 0012A for Moderna’s vaccine and administration.
Brief, medium, and lengthy descriptions for all the brand new vaccine-specific CPT codes will also be accessed on the AMA web site. The Affiliation additionally provides on its web site different current modifications to the CPT code set associated to COVID-19 and the general public well being response effort.
AMA can be publishing the 2 new CPT codes now to make sure EHR programs are up to date and suppliers are ready for any FDA approvals for authorization for the Janssen COVID-19 vaccine.